T HE PRECISE MECHANISMS underlying the initiation
of human labor are unknown, but increasing evidence suggests that myometrial smooth muscle calcium dynamics are modulated toward the end of gestation to facilitate uterine contractility (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . In human myometrium, the development of force is predominantly dependent on calcium entry from the extracellular milieu (11) . The major route of calcium entry is via voltage-gated calcium channels (12, 13) , and considerable evidence suggests that L-type channels are up-regulated during labor (2, 9) . Other nonvoltage calcium entry pathways [e.g. store-operated calcium entry (SOCE) and non-SOCE] have been implicated in human myometrium (14 -16) , but the relative contribution of these to the initiation and development of rhythmic myometrial contractile activity during labor has yet to be established.
SOCE and non-SOCE (which are closely related to receptor-operated calcium entry) have been described in numerous excitable and nonexcitable cells and provide alternative pathways by which agonists can augment and maintain calcium entry (17) (18) (19) . SOCE is activated by depletion of the inositol triphosphate-sensitive sarcoplasmic reticulum (SR) calcium stores. Depletion of the SR calcium stores, and hence SOCE, can be initiated by endogenous agonists binding to G protein-coupled receptors or pharmacologically by agents (cyclopiazonic acid and thapsigargin) that inhibit the SR calcium ATPases (SERCA). Non-SOCE is activated by intermediate signaling molecules (e.g. arachidonic acid and diacylglycerol) of the phospholipase C signaling cascade (17, 18) . SOCE/non-SOCE pathways have been described in immortalized pregnant human myometrial cells (16) and in primary cultured human myometrial smooth muscle (HMSM) cells (10, 15) . The contribution of SOCE/non-SOCE to human myometrial contractility remains to be fully characterized; however, we have shown that cyclopiazonic acid (which activates SOCE) evokes contractions in term pregnant human myometrium in vitro and that this response is substantially exaggerated in myometrial tissue from women in labor (10) . Preliminary evidence from our laboratory has demonstrated that myometrial contractions can be induced after SR calcium store depletion in the presence of a L-type calcium channel inhibitor (14) , indicating that other calcium entry pathways exist. We have also reported that the proinflammatory cytokine IL-1␤, which is implicated in the initiation of preterm and term labor (20, 21) , induces calcium oscillations and SOCE in primary cultured HMSM cells (15) .
The proteins forming SOCE/non-SOCE channels in human myometrium have yet to be identified, but transient receptor potential canonical (TrpC)1-7 proteins, which are associated with SOCE/non-SOCE in other cells types (22) (23) (24) (25) (26) (27) (28) (29) , are potential candidates. TrpC proteins are subdivided into two subgroups on the basis of sequence homology. One subgroup includes TrpC1, TrpC4, and TrpC5; and TrpC3, TrpC6, and TrpC7 form the other. Recent coimmunoprecipi-tation studies have demonstrated that TrpC proteins form homo-or heteromeric channels in vivo and that functional channels are subgroup specific (27) . There is also emerging evidence for an involvement of TrpC proteins in the generation of calcium oscillations and pacemaker activity in smooth muscle (29 -32) .
Recent studies have demonstrated that TrpC1, TrpC3, TrpC4, TrpC6, and TrpC7 mRNA and also TrpC1, TrpC3, TrpC4, and TrpC6 proteins are expressed by term human myometrial tissue (33, 34) and primary cultured HMSM cells (33) , and overexpression of TrpC3 in human myometrial cells is linked with enhanced SOCE/non-SOCE (35) . We hypothesize that if TrpC proteins contribute to SOCE/non-SOCE and contractile activity in HMSM, then TrpC isoforms will show evidence of regulation during pregnancy and labor. Similarly, we would predict the up-regulation of one or more TrpC isoforms in IL-1␤-treated HMSM cells in parallel with the induction of calcium oscillations and non-SOCE/SOCE.
Subjects and Methods Subjects
Human myometrial biopsies were obtained at cesarean section, with informed written consent and institutional Ethics Committee approval (Walsgrave Hospital Trust, Coventry, UK and Guy's and St. Thomas' Hospital Trusts, London, UK) in accordance with the principles set out in the Declaration of Helsinki. Biopsies were collected for RNA isolation (Walsgrave Hospital Trust) from women without underlying disease at term not in labor (TNL, n ϭ 7, 37-40 wk; indications: maternal request, breech presentation, previous section, or placental praevia) and term in active labor [TAL, n ϭ 5, 39 -41 wk; indications: failure to progress (without syntocin or prostaglandin administration), fetal distress, or previous section]. Biopsies were also collected for protein isolation (Guy's and St. Thomas' Hospital Trusts) from women without underlying disease at TNL (n ϭ 5, 38 -41 wk; indications: breech presentation or previous section) and TAL [n ϭ 5, 39 -42 wk; indications: failure to progress (without syntocin or prostaglandin administration), fetal distress, or undiagnosed breech]. Myometrium was collected (Guy's and St. Thomas' Hospital Trusts) from premenopausal nonpregnant (NP) women at the time of hysterectomy for dysmenorrhea and used for RNA (n ϭ 3) and protein isolation (n ϭ 3). After collection, samples were snap frozen. TNL myometrial biopsies (n ϭ 13, 38 -40 wk, indications: previous section, breech presentation, perforated bowel, or maternal request) were also collected for primary cell culture (Guy's and St. Thomas' Hospital Trusts).
Cell isolation and primary culture of HMSM cells
HMSM cells were isolated as described previously from TNL myometrial biopsies (10, 33) . In initial experiments, confluent primary HMSM cell cultures (from n ϭ 10 women, n ϭ 3 for RNA, and n ϭ 7 for protein isolation) were serum deprived for 24 h [DMEM (Sigma, Poole, UK) plus 0.5% fetal calf serum (FCS; Invitrogen, Paisley, UK)] and then incubated (DMEM, 0.5% FCS, 24 h) with 10 ng/ml IL-1␤ (stock prepared in DMEM, 0.5% FCS; R&D Systems, Oxon, UK) or DMEM plus 0.5% FCS (control). A second group of experiments were performed to determine the potential influence of cytokine-induced prostaglandin production on TrpC protein expression because IL-1␤ also induces cyclooxygenase (COX)-2 and prostaglandin production in HMSM cells (36) . Primary HMSM cell cultures (from n ϭ 3 women) were serum deprived (DMEM, 0.5% FCS, 24 h) and then incubated (DMEM, 0.5% FCS, 24 h) either without (controls) or with 10 ng/ml IL-1␤ or 10 ng/ml IL-1␤ plus 10 m nimesulide (COX-2 inhibitor, Sigma) or 10 m nimesulide alone. The IL-1␤ concentration used was within the range reported for cervicovaginal secretions of women in term and also preterm labor (20, 21) .
RT-PCR
Total RNA was isolated from myometrial tissue using the SV Total RNA Isolation System (Promega, Southampton, UK) as recommended by the manufacturer. RNA was isolated from IL-1␤-treated and control primary HMSM cell cultures using Trizol reagent (Invitrogen Life Technologies). Reverse transcription was carried out using random hexanucleotide primers (0.2 g) and total RNA (100 ng), which was first denatured at 70 C for 5 min followed by reverse transcription with Superscript II (Invitrogen Life Technologies) at 37 C for 60 min. The resultant cDNA was used as template for PCR with 1.25 U AmpliTaq (conditions as recommended by Applied Bioscience, Cheshire, UK) and 125 ng of 5Ј and 3Ј with TrpC gene-specific primers (33) . PCR primers (5Ј-3Ј) were: TrpC1 (sense) ACAGCAAAGCAATGATACCT, (antisense) AAGTCCGAAAGCCAAGTAAA; TrpC3 (sense) GTTGTGGAATGT-GCTTGACT, (antisense) TGAAAGGTGGAGGTAATGTT; TrpC4 (sense) CCTGGACATTTTGAAGTTTC, (antisense) CTGCATGGTCAG-CAATCAGT; TrpC6 (sense) AGGATGACGCTGATGTGGAG, (antisense) TCCTTCAGTTCCCCTTCGTT; and TrpC7 (sense) ATGCCTTT-GGCGACATCGTCTTCA, (antisense) TCCTCATCCAGTATGTACT (33) . PCR products were 620 (TrpC1), 722 (TrpC3), 356 (TrpC4), 454 (TrpC6), and 432 (TrpC7) bp (Fig. 1) . Cycling parameters used were: cycles of denaturing at 94 C for 30 sec; annealing at 48 C (TrpC7), 51 C (TrpC4), 54 C (TrpC1), or 57 C (TrpC3 and TrpC6) for 30 sec; extension at 72 C for 30 sec; followed by a final extension of 5 min at 72 C. After amplification, PCR products were analyzed using ethidium bromidestained agarose gels, subcloned into the pGEM-T Easy vector (Promega) and sequence verified.
For each target gene investigated, a cycle profile was performed on pooled myometrial tissue or HMSM cell cDNA to determine the exponential phase of amplification. PCR was performed using each pooled cDNA sample and TrpC primers. Samples were amplified for 20 -42 PCR cycles at two cycle intervals, analyzed using ethidium bromidestained agarose gels, and the exponential phase of amplification determined. The exponential phase cycle number (33 for TrpC1 and 36 for TrpC3, TrpC4, TrpC6, and TrpC7) was used for gene expression analysis. Subsequent PCR experiments were analyzed by agarose gel electrophoresis and quantified using TotalLab software (Newcastle upon Tyne, UK). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression (primers 5Ј-3Ј, sense-CCA CCC ATG GCA AAT TCC ATG GCA, antisense-TCT AGA CGG CAG GTC AGG TCC ACC; annealing temperature, 58 C; 587-bp product) was also determined in all samples. GAPDH expression was variable (mean Ϯ se GAPDH mRNA expression arbitrary units; NP, 0.030 Ϯ 0.005, n ϭ 3; TAL, 0.067 Ϯ 0.002, n ϭ 5; TNL, 0.049 Ϯ 0.003, n ϭ 7; NL vs. AL P Ͻ 0.001, NP vs. TNL P Ͻ 0.01; TAL vs. TNL P Ͻ 0.01) as has been reported in pregnancy for this gene and other house-keeping genes (37, 38) . Calponin mRNA expression was equally as variable; and therefore, uncorrected TrpC mRNA expression data are presented.
FIG. 1. TrpC1
(620 bp), TrpC3 (722 bp), TrpC4 (356 bp), TrpC6 (454 bp), and TrpC7 (432 bp) PCR products in NP (n ϭ 3); TAL (n ϭ 5) and term nonlabor (n ϭ 7 for TrpC1, 4, 6, and 7; n ϭ 6 for TrpC3) myometrial samples. PCR products were loaded onto the gels in an identical order to enable TrpC expression profiles to be determined for each patient.
Western blotting
Human myometrial biopsies were homogenized using an Ultra Turrax T50 homogenizer in 20 l of homogenization buffer per milligram of tissue [10 mmol/liter HEPES-KOH, pH 7; 1 mmol/liter dithiothreitol; 1% (vol/vol) nonidet-P40 (Sigma) and protease inhibitor cocktail (COM-PLETE tablets; Roche Molecular Biochemicals, Lewes, UK)]. Confluent primary cultured HMSM cells were detached from 3-cm culture dishes using 100 l homogenization buffer (as above). Proteins were separated from cell debris by centrifugation (13,000 ϫ g, 10 min, 4 C) and the protein concentration in all samples determined using BSA as a standard and the DC protein assay kit (Bio-Rad Laboratories Ltd, Herts, UK).
Myometrial tissue proteins (10 g) and primary cultured HMSM cellular proteins (10 g) were denatured at 95 C for 10 min in Laemmli sample buffer (Sigma), size separated using Novex 10% Tris-Glycine gels (Invitrogen), and then transferred to polyvinylidene difluoride membrane (Amersham Pharmacia Biotech Ltd, Buckinghamshire, UK). The transfer efficiency and equal loading of protein samples was assessed by incubating membranes with Ponceau red solution (Sigma). After transfer, membranes were washed with PBS-T (PBS, 0.1% Tween-20, Sigma) and incubated (overnight, 4 C) in blocking buffer (PBS-T, 5% goat serum; Chemicon, Harrow, UK) and subsequently incubated (2 h, room temperature) with the desired rabbit polyclonal primary antibody. Primary antibodies used were TrpC1 (25, 1:1000), TrpC3, TrpC4, or TrpC6 (Alomone Labs, Jerusalem, Israel, 1:200), which were diluted in blocking buffer. For the negative controls, membranes were incubated with a 1:1000 dilution of rabbit preimmune serum (TrpC1) or incubated with primary antibodies that were preabsorbed (1 h, room temperature) with the respective peptides (TrpC3, TrpC4, or TrpC6, Alomone Labs, as recommended by the supplier). After incubation with the primary antibody or negative control, membranes were incubated (1 h, room temperature) with a horseradish peroxidase conjugated goat antirabbit secondary antibody (Bio-Rad, diluted 1: 2500 in blocking buffer). Thereafter, membranes were washed in PBS-T (4 ϫ 15 min) and protein bands visualized with ECL (Amersham Pharmacia Biotech Ltd). Hyperfilms were developed before the saturation of TAL samples. TrpC7 protein expression was not investigated because a commercial TrpC7 antibody is currently unavailable.
Statistical analysis
PCR products were quantified using TotalLab software, and Western blotting hyperfilms were analyzed using the Bio-Rad Multi-Analyst, version 1.1 (Bio-Rad, Hemel Hempstead, UK). Both software packages allow calculation of the density of each band and corresponding background values. Final intensity values (arbitrary units) were background subtracted. PCR and Western blotting data were analyzed using ANOVA with Tukey-Kramer multiple-comparison test or Student's t test. A value of P Յ 0.05 was considered significant. Data are expressed as mean Ϯ sem. N refers to numbers of individual myometrial samples or primary cell cultures used and correspond directly to patient number.
Results

Gestational regulation of TrpC mRNA in human myometrial tissue
PCR amplified TrpC1 (620 bp), TrpC3 (722 bp), TrpC4 (356 bp), TrpC6 (454 bp), and TrpC7 (432 bp) products (Fig. 1) in   FIG. 2 . Graphs depicting mean Ϯ SEM of TrpC isoform PCR densitometry analysis. A, TrpC1 mRNA was significantly increased in TAL and TNL when compared with NP myometrial samples. TAL and TNL samples expressed TrpC1 mRNA at a similar level. B, TrpC3 mRNA expression was similar in NP, TAL, and TNL myometrial samples. C, TrpC4 mRNA expression was similar in NP, TAL, and TNL myometrial samples. D, TrpC6 mRNA was significantly increased in the TAL when compared with TNL and NP myometrial samples. E, TrpC7 was significantly increased in TAL samples when compared with NP and TNL samples. *, P Յ 0.05; **, P Յ 0.01. NP n ϭ 3, TAL n ϭ 5, and TNL n ϭ 7 for TrpC1, 4, 6, and 7; n ϭ 6 for TrpC3.
human myometrial tissue (NP, n ϭ 3; TAL, n ϭ 5; TNL, n ϭ 6 -7). Products were of the expected size and consistent with our previous observations (33) . No bands were amplified in reverse-transcribed or PCR-negative controls (data not shown).
Semiquantification demonstrated that TrpC1 mRNA was significantly up-regulated in TAL and TNL myometrium when compared with NP samples (Figs. 1 and 2A 
Gestational regulation of TrpC proteins in human myometrial tissue
Western blotting detected TrpC1 [90 relative molecular mass (m r ϫ 10 Ϫ3 )], TrpC3 (90 m r ϫ 10 Ϫ3 ), TrpC4 (100 m r ϫ 10 Ϫ3 ), and TrpC6 (100 m r ϫ 10 Ϫ3 ) proteins in pregnant human myometrial tissue (Fig. 3) as previously reported (33) . No bands were observed when the primary antibody was omitted or when primary antibodies were preabsorbed with the appropriate peptide (data not shown).
TrpC1 protein expression was not detected in NP myometrium but was significantly increased in TAL and TNL when compared with NP samples (Figs. 3 and 4A ; NP, 0.000 Ϯ 0.000; TAL, 0.076 Ϯ 0.020; TNL, 0.074 Ϯ 0.014; P Յ 0.05). There was no significant difference in TrpC1 protein expression between TNL and TAL myometrial samples. TrpC3 protein expression was minimal in the NP and TNL myometrium; however, expression was significantly increased in TAL when compared with NP and TNL myometrial samples ( Figs. 3 and 4B ; NP, 0.003 Ϯ 0.003; TAL, 0.062 Ϯ 0.009; TNL, 0.022 Ϯ 0.007; P Յ 0.01). TrpC4 protein expression was not detected in the NP myometrium, was minimally expressed in TNL myometrium, and was significantly increased in TAL myometrial samples ( Figs. 3 and 4C ; NP, 0.000 Ϯ 0.000; TAL, 0.118 Ϯ 0.039; TNL, 0.018 Ϯ 0.007; P Յ 0.05). Similarly, TrpC6 protein expression was not detected in the NP myometrium, was minimally expressed in TNL myometrium, but was significantly increased (P Յ 0.01, NP compared with TAL; P Յ 0.05, TAL compared with TNL) in TAL myometrial samples ( Figs. 3 and 4D ; NP, 0.000 Ϯ 0.000; TAL, 0.072 Ϯ 0.012; TNL, 0.036 Ϯ 0.007). We previously reported TrpC1, TrpC3, TrpC4, and TrpC6 expression in membrane-enriched TNL protein samples (33), whereas total cellular proteins were used in this study, which possibly accounts for the relatively lower level of expression in TNL samples. In addition, hyperfilms were developed before saturation of TAL samples to enable quantification.
Regulated expression of TrpC mRNA by IL-1␤
PCR amplified TrpC1 (620 bp), TrpC3 (722 bp), TrpC4 (356 bp), and TrpC6 (454 bp) products in control and IL-1␤- treated primary HMSM cell cultures (n ϭ 3, Fig. 5 ). TrpC7 (432 bp) was not expressed in all primary myometrial cell cultures (Fig. 5) , which is consistent with our previous studies (33) . 
Regulated expression of TrpC proteins by IL-1␤
TrpC1, TrpC3, TrpC4, and TrpC6 proteins expressed in primary HMSM cell cultures (Fig. 7) were of an identical size to that of proteins expressed by human tissue and observed previously in HMSM cells (33) . No bands were observed when the primary antibody was omitted or when primary antibodies were preabsorbed with the appropriate peptide (data not shown). IL-1␤ treatment differentially regulated TrpC isoform protein expression in TNL primary HMSM cell cultures isolated from n ϭ 7 myometrial biopsies. IL-1␤ significantly up-regulated TrpC3 protein expression com- (Figs. 7 and 8, A, C, and D) . It was also noted that TrpC1 protein expression was absent in a number of HMSM primary cell cultures (three out of seven). This may be due to the fact that the cells were serum deprived; in other cell types, FCS regulates TrpC1 gene expression (39) . TrpC3 was observed to be a doublet; in other cell types, the upper band corresponds to the glycosylated form of the protein (40) . TrpC4 protein doublets were also detected, and possibly correspond to TrpC4-␣ and TrpC4-␤ splice variants (41), previously shown (33) .
Does IL-1␤ regulate TrpC3 protein via COX-2 induction?
To determine whether IL-1␤-induced TrpC3 expression is mediated via COX-2-driven prostaglandin production, primary HMSM cell cultures (n ϭ 3) were incubated with IL-1␤ in the presence and absence of the COX-2 inhibitor nimesulide (Fig. 9, A and B) . TrpC3 protein bands were not detected in untreated control cells, but IL-1␤ significantly up-regulated TrpC3 protein expression (IL-1␤ vs. control, 0.29 Ϯ 0.05 vs. 0.00 Ϯ 0.00, P Յ 0.01). However, this up-regulation was not inhibited by nimesulide (IL-1␤ plus nimesulide vs. control, 0.37 Ϯ 0.07 vs. 0.00 Ϯ 0.00, P Յ 0.01). There was no significant difference in the level of TrpC3 protein expression between IL-1␤-and IL-1␤-plus-nimesulide-treated cells (IL-1␤ vs. IL-1␤ ϩ nimesulide, 0.29 Ϯ 0.05 vs. 0.37 Ϯ 0.07, N.S.). Western blotting was also performed for TrpC1, TrpC4, and TrpC6; proteins were expressed at a similar level in control, IL-1␤-, and IL-1␤-plus-nimesulide-and nimesulide-treated cells (data not shown).
Discussion
To our knowledge, this is the first direct demonstration to suggest that TrpC mRNA and protein are modulated by a normal physiological process, because this study has shown a substantial pregnancy related increase in myometrial TrpC isoform expression. We also propose that IL-1␤ may play a mechanistic role, because this cytokine induced TrpC3 protein expression in primary cultured HMSM cells. 
Gestational changes in TrpC mRNA and protein expression
Overall, the data imply that all the TrpC proteins investigated, putative components of SOCE and non-SOCE channels, are up-regulated in human myometrium during pregnancy and labor when compared with the NP state. Thus our study substantiates, and considerably expands on, an earlier report from our group that demonstrated the presence of TrpC proteins in term nonlaboring myometrium. The changing role of the pregnant uterus encompasses growth and coordinated contractile activity. Whatever the role of the individual TrpC proteins, the general increase of TrpC expression in pregnancy is strongly indicative of a role for these proteins in one or more of these functional adaptations of the uterus to pregnancy.
Of the TrpC isoforms studied, only TrpC6 and TrpC1 mRNA were translated to corresponding increases in protein expression. TrpC1 protein expression increased before labor and was maintained at a similar level during labor. TrpC6 protein expression was higher in labor than NP samples but, in contrast to the mRNA data, was also greater than in nonlaboring myometrium. TrpC3 and TrpC4 proteins were also substantially increased in labor compared with NP and nonlaboring groups, but this was not reflected by an increase in mRNA expression. Interestingly, TrpC1 mRNA and protein was the only isoform to be strongly expressed before labor, suggesting that it may be differentially regulated to other isoforms and perform different functions in myometrium. The simultaneous increase in several TrpC isoforms may have functional importance through de novo SOCE and non-SOCE channel formation because expression levels of individual TrpC proteins are known to influence the composition of heterotetrameric channels and thereby modulate ion permeability and activation properties (18, 23, 42) .
The differences between mRNA and protein expression of individual TrpC isoforms require comment because there are a number of potential explanations. For most of the isoforms (TrpC1, 3, and 6), the mRNA expression pattern mirrored protein expression but did not attain significance. This may be due to lack of statistical power, but the sample number was limited by the gel size, and cross gel analysis is not recommended in studies of this kind. Also, a closer association with mRNA and protein may have been observed if the assays had been performed on paired samples. More likely, however, the alterations in gene expression may have occurred in anticipation of delivery, as suggested by Challis (43) , and would therefore be undetectable in nonlaboring and laboring samples from women at term. Although mRNA and protein generally showed a similar profile, TrpC4 mRNA expression was distinctly different from protein expression in labor that is indicative of posttranslational modulation. Similarly, TrpC1, 3, 4, and 6 mRNA was detected in NP myometrium, but protein expression is very low, which may again indicate posttranscriptional and/or posttranslational events.
Some of the difference between TrpC protein expression in pregnant and NP myometrium could theoretically be accounted for by differences in cell size (44) , which would influence protein content. The magnitude of the difference was, however, far greater than possibly explicable on this basis. Also this cannot provide an explanation for the marked increase in protein expression associated with labor because term tissue will have similar cell size and water content.
The functional impact of altered TrpC protein expression in labor is unknown, because a direct link between TrpC proteins and myometrial contraction has yet to be demonstrated. However, endogenous TrpC1, TrpC3, TrpC4, and TrpC6 proteins have been found to form SOCE and non-SOCE channels in other cell systems (24, 25, 29, 30, (45) (46) (47) (48) . Importantly, the up-regulation of TrpC proteins at term and during labor parallels an increase in myometrial SERCA expression (10) . Inhibition of SERCA by cyclopiazonic acid induces SOCE, and previous functional studies from our laboratory have shown that cyclopiazonic acid-induced contractions are substantially enhanced in myometrial tissue from women in labor (10) . This synchrony of events strongly supports the hypothesis that TrpC proteins form SOCE/ non-SOCE channels in human myometrium.
Stimuli for increased TrpC protein expression
The regulation of TrpC protein expression is poorly understood. A few in vitro studies in other cell types have demonstrated up-regulation of TrpC1 and TrpC6 mRNA by serum and growth factors (39, 49 -51) , TrpC3 mRNA by ␤-estradiol, and progesterone and down-regulation of TrpC4 mRNA by ␤-estradiol (52) . In pregnancy the most likely candidates are placental steroids, uterine stretch, and inflammatory cytokines. Cytokines (IL-1␤, IL-6, and IL-8) are highly expressed in human myometrial tissue from women in labor (53) (54) (55) , and IL-1␤ initiates uterine contractions in the primate (56, 57) . In the present study, prolonged IL-1␤ exposure significantly up-regulated TrpC3 protein expression in primary cultured HMSM cells without altering TrpC3 mRNA expression, indicative of posttranscriptional/translational regulation or alternatively transient changes in mRNA expression before protein evaluation at 24 h. Indeed, other studies have shown a temporal dissociation between IL-1␤-induced COX-2 mRNA and protein expression (36, 58) .
The IL-1␤-induced increase in TrpC3 protein expression parallels the up-regulation of SERCA 2b protein expression and enhanced calcium oscillations in primary cultured HMSM cells by the same cytokine, which we have previously reported (15) . Up-regulation of basal calcium entry (non-SOCE) and SOCE have been reported in a human embryonic kidney and myometrial cell lines in which TrpC3 is overexpressed (35, 59, 60) . Similarly, the increase in TrpC3 protein expression in IL-1␤-treated HMSM cells is associated with a predominant non-SOCE pathway that seems to underlie the initiation of calcium oscillations (15) . The link between TrpC3 proteins and calcium oscillations is also supported by a recent antisense study that clearly demonstrated that endogenous TrpC3 proteins facilitate 1-oleoyl-2-acetyl-sn-glycerol (a stable analog of diacylglycerol)-induced calcium oscillations in rat embryonic astrocytes (29) . Further studies, will determine conclusively whether IL-1␤, and other relevant cytokines, influence TrpC3 expression and contractility in human myometrial biopsies as well as HMSM cells and whether TrpC expression is altered in myometrium from preterm deliveries associated with infection and chorioamnionitis.
The mechanism by which IL-1␤ increases TrpC3 protein expression requires elucidation. There is evidence that IL-1␤ induces COX-2 expression in HMSM cells (36) and that IL-1␤ induced contractions are inhibited by the nonselective COX inhibitor indomethacin (61) . We addressed this in the present study by addition of the COX-2 inhibitor nimesulide. The lack of effect of nimesulide on TrpC3 protein expression suggests that IL-1␤-induced TrpC3 expression and, by inference, HMSM cell excitability (15) are COX-2 independent. However, in vivo, TrpC3 proteins could facilitate myometrial activation before, or in tandem with, prostaglandin synthesis, so contributing to the cassette of contraction-associated proteins (43) .
In summary, we have shown, for the first time, that TrpC1, TrpC6, and TrpC7 mRNA and TrpC1, TrpC3, TrpC4, and TrpC6 proteins are gestationally regulated in the human myometrium and that IL-1␤ exclusively regulates TrpC3 protein expression in primary cultured HMSM cells. Although the functional role remains to be elucidated, this study provides novel molecular evidence for TrpC calcium entry channels in human myometrium.
